Abstract | OBJECTIVE: METHODS: RESULTS: A total of 64 patients (34 men) with a mean (+/-SD) age of 47.1 +/- 15.4 years were included. There were 37 cases of pleural effusion and 27 of pneumothorax. A complete response (neither reaccumulation of fluid nor recurrence of pneumothorax) was obtained in 32 (86.5%) patients with pleural effusion and 25 (92.6%) patients with pneumothorax. A second procedure (i.e. repeated pleurodesis) was attempted successfully in four patients in the pleural effusion group. All patients experienced chest pain to a varying degree as recorded on a Visual Analogue Scale (median 50.5, range 10-95). Seven patients developed fever and one immunocompromised patient developed empyema following the procedure. There were no recurrences at a median follow up of 5 months (range 3-15 months) in the pleural effusion group, and 13 months (range 6-24 months) in the pneumothorax group. CONCLUSIONS: Iodopovidone can be used as an effective and safe agent for (chemical) pleurodesis (through tube thoracostomy), which is inexpensive and readily available.
|
Authors | Ritesh Agarwal, Ashutosh N Aggarwal, Dheeraj Gupta |
Journal | Respirology (Carlton, Vic.)
(Respirology)
Vol. 11
Issue 1
Pg. 105-8
(Jan 2006)
ISSN: 1323-7799 [Print] Australia |
PMID | 16423210
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Anti-Infective Agents, Local
- Sclerosing Solutions
- Povidone-Iodine
|
Topics |
- Anti-Infective Agents, Local
(administration & dosage, adverse effects)
- Chest Tubes
- Female
- Humans
- Male
- Middle Aged
- Pleural Effusion
(drug therapy)
- Pleurodesis
(methods)
- Pneumothorax
(therapy)
- Povidone-Iodine
(administration & dosage, adverse effects)
- Prospective Studies
- Recurrence
- Safety
- Sclerosing Solutions
(administration & dosage, adverse effects)
- Thoracostomy
|